Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueTax ProvisionsTax Rate
Others
Ratios

Metlife (MET-PA) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $818.0 million.

  • Metlife's Net Income towards Common Stockholders fell 3584.31% to $818.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 205.0%. This contributed to the annual value of $4.2 billion for FY2024, which is 20623.19% up from last year.
  • Per Metlife's latest filing, its Net Income towards Common Stockholders stood at $818.0 million for Q3 2025, which was down 3584.31% from $698.0 million recorded in Q2 2025.
  • In the past 5 years, Metlife's Net Income towards Common Stockholders ranged from a high of $3.4 billion in Q2 2021 and a low of $14.0 million during Q1 2023
  • Over the past 5 years, Metlife's median Net Income towards Common Stockholders value was $881.0 million (recorded in 2022), while the average stood at $1.0 billion.
  • In the last 5 years, Metlife's Net Income towards Common Stockholders tumbled by 9910.88% in 2023 and then skyrocketed by 561428.57% in 2024.
  • Over the past 5 years, Metlife's Net Income towards Common Stockholders (Quarter) stood at $1.5 billion in 2021, then increased by 4.87% to $1.5 billion in 2022, then tumbled by 62.94% to $574.0 million in 2023, then skyrocketed by 115.85% to $1.2 billion in 2024, then crashed by 33.98% to $818.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at $818.0 million for Q3 2025, versus $698.0 million for Q2 2025 and $879.0 million for Q1 2025.